English Français

The RECOVERED Project is a Canada-wide project being conducted by the UBC Reproductive Infectious Diseases Program and is investigating Respiratory Syncytial Virus (RSV) Vaccines in pregnancy. The RECOVERED project aims to broaden our understanding of vaccine attitudes, pregnancy outcomes, and infant outcomes related to maternal vaccination and infant monoclonal antibody treatment for RSV. The data is being collected from pregnant women and people, regardless of vaccination status or monoclonal antibody status of their infants. By gathering online survey data on knowledge and perception of RSV as well as feelings, opinions, and attitudes towards RSV vaccination and infant monoclonal antibody, this project will examine RSV acceptability, safety, and efficacy of infant RSV prevention interventions among pregnant people in Canada. It is through this study that we hope to help health care institutions and care practitioners provide up-to-date recommendations regarding RSV vaccination for pregnant women and people, and also help future parents make informed health decisions during pregnancy.

The RECOVERED project is now open for recruitment, so if you are interested in participating please click here to get more information and to access our e-consent!

---

Coordinating Centre Lead: Dr. Deborah Money, MD, FRCSC, Professor; University of British Columbia Depts. of Obstetrics & Gynecology, Medicine, SPPH, Clinician Scientist, Women’s Health Research Institute

For further information, please visit the RECOVERED project website or email the RECOVERED Team at recovered.rsv@ubc.ca

---

For supporting information please reference the sections below